Mark D. Pegram, MD | Authors

Mark Pegram, MD, Reviews Utility of Breast Cancer Index in Early-Stage HR+ Breast Cancer

June 28, 2022

Mark Pegram, MD, spoke about using the Breast Cancer Index and Clinical Treatment Score post-5 years to determine outcomes for patients with early-stage hormone receptor–positive breast cancer treated with adjuvant endocrine therapy.